You have 9 free searches left this month | for more free features.

BDP

Showing 1 - 25 of 138

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB

Recruiting
  • Asthma
  • Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
  • +2 more
  • Edegem, Antwerpen, Belgium
    SGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

ivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs

Not yet recruiting
  • COPD
    • Budapest, Hungary
      National Korányi Institute of Pulmonology
    Feb 15, 2023

    Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy

    Not yet recruiting
    • Asthma
    • (no location specified)
    Oct 24, 2023

    Pulmonary Disease, Chronic Obstructive, Asthma Trial in Gauting (BDP/formoterol NEXT DPI)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Asthma
    • BDP/formoterol NEXT DPI
    • Gauting, Germany
      Inamed Research GmbH & Co. KG
    Oct 28, 2021

    Mild Persistent Asthma Trial in London (BDP/formoterol, Placebo)

    Completed
    • Mild Persistent Asthma
    • London, United Kingdom
      Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Str
    Oct 28, 2021

    Effectiveness, and Safety ofFixed-dose Combination of

    Not yet recruiting
    • Plaque Psoriasis
    • CAL/BDP PAD Cream
    • (no location specified)
    Mar 31, 2023

    Asthmatic Trial in Manchester (NEXThaler 100/6 mcg DPI, Flixotide Accuhaler 500 mcg, NEXThaler 200/6 mcg DPI)

    Completed
    • Asthmatic
    • NEXThaler 100/6 mcg DPI
    • +3 more
    • Manchester, United Kingdom
      The Medicine Evaluation Unit
    Oct 28, 2021

    Asthma Trial (MF/F Metered Dose Inhaler (MDI) 25/5 mcg, MF/F MDI 50/5 mcg, MF/F MDI 100/5 mcg)

    Withdrawn
    • Asthma
    • MF/F Metered Dose Inhaler (MDI) 25/5 mcg
    • +6 more
    • (no location specified)
    Feb 7, 2022

    Real-life: Impact on Adherence and Health Status (TRITRIAL)

    Completed
    • COPD
    • BDP/FF/G fixed combination
    • Rome, Italy
      Fondazione Policlinico Gemelli
    May 4, 2022

    PASS to Assess Cardiovascular and Cerebrovascular Events in COPD

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease
    • Observational retrospective data collection
    • (no location specified)
    Dec 14, 2022

    Healthy Adult Male Volunteers Trial in Verona (Beclomethasone dipropionate)

    Completed
    • Healthy Adult Male Volunteers
    • Beclomethasone dipropionate
    • Verona, Italy
      Centro Ricerche Cliniche AOU Integrata di Verona - Policlinico U
    May 3, 2022

    Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)

    Not yet recruiting
    • Asthma
    • Beclomethasone Dipropionate/Formoterol Fumarate
    • Beclomethasone Dipropionate
    • (no location specified)
    Mar 14, 2022

    COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Godollo, Hungary
      Erzsebet Gondozohaz
    Oct 28, 2021

    COPD Trial in Hessen, Szeged, Perugia (BDP/FF/GB, Tiotropium, BDP/FF + Tiotropium)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Hessen, Germany
    • +2 more
    Oct 28, 2021

    Pulmonary Disease, Chronic Obstructive Trial in Manchester (Glycopyrrolate, Comparator)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Manchester, United Kingdom
      Medicines Evaluation Unit Ltd.
    Oct 28, 2021

    Pulmonary Disease, Chronic Obstructive Trial in London (CHF1535, Formoterol fumarate)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • London, United Kingdom
      UCL Medical School
    Oct 28, 2021

    Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)

    Completed
    • Asthma
    • CHF1535 200/6 µg
    • BDP 100 µg
    • Pisa, Italy
      Cardio-Thoracic and Vascular Dept, University of Pisa
    Oct 28, 2021

    BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD

    Not yet recruiting
    • COPD, Chronic Obstructive Pulmonary Disease
      • Parma, Italy
        Department of Medicine and Surgery, Respiratory Disease and Lung
      Oct 28, 2021

      Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)

      Completed
      • Asthma
      • Chronic Obstructive Pulmonary Disease
      • Therapeutic Dose 1
      • +3 more
      • London, Tooting, United Kingdom
        Richmond Pharmacology Ltd
      Oct 15, 2021

      COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)

      Completed
      • COPD
      • CHF 1535 NEXThaler 800/48
      • +4 more
      • Manchester, United Kingdom
        Medicine Evaluation Unit
      Oct 28, 2021

      Rhinitis, Allergic, Perennial Trial in United States (Beclomethasone dipropionate, Placebo Nasal Aerosol)

      Completed
      • Rhinitis, Allergic, Perennial
      • Beclomethasone dipropionate
      • Placebo Nasal Aerosol
      • Oxford, Alabama
      • +33 more
      Dec 1, 2021

      Seasonal Allergic Rhinitis, Hay Fever Trial in United States (Beclomethasone dipropionate, Placebo Nasal Aerosol)

      Completed
      • Seasonal Allergic Rhinitis
      • Hay Fever
      • Beclomethasone dipropionate
      • Placebo Nasal Aerosol
      • Austin, Texas
      • +3 more
      Dec 1, 2021

      Asthma Trial in Copenhagen (CHF1535 pMDI + AC Plus, BDP + AC Plus, Formoterol + AC Plus)

      Completed
      • Asthma
      • CHF1535 pMDI + AC Plus
      • +2 more
      • Copenhagen, Denmark
        BorneAstmaKlinikken
      Jul 30, 2020